StratifiCare is a Singapore medical technology company founded in 2015 with the vision of empowering personalized medicine for tomorrow. The team has more than 100 years of combined experience in medical technology innovation. Through the development of innovative, technologically advanced in vitro diagnostic solutions, the company aims to transform the way patients are managed through personalized care and create value for all. StratifiCare recently secured close to S$1 million in an oversubscribed Seed round from prominent investors to advance the development of their products to the next level.